Home › Compare › STSC vs MRK

STSC vs MRK: Dividend Comparison 2026

STSC yields 1000000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STSC wins by $4.7683925249533696e+36M in total portfolio value
10 years
STSC
STSC
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full STSC calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — STSC vs MRK

📍 STSC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTSCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STSC + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
STSC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STSC
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, STSC beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STSC + MRK for your $10,000?

STSC: 50%MRK: 50%
100% MRK50/50100% STSC
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

STSC
No analyst data
Altman Z
0.0
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STSC buys
0
MRK buys
0
No recent congressional trades found for STSC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTSCMRK
Forward yield1000000.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$4.7683925249533696e+36M$30.7K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$950.29
Total dividends collected$4.7683311610149396e+36M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: STSC vs MRK ($10,000, DRIP)

YearSTSC PortfolioSTSC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,192$351.54+$100.00M → STSC
2$934,786,450,701$934,679,439,252.34$12,524$392.70+$934786.44M → STSC
3$8,165,787,108,578,292$8,164,786,887,076,042.00$14,015$438.65+$8165787108.56M → STSC
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$15,682$489.96+$66665884190957.63M → STSC
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$17,547$547.23+$508662171058048128.00M → STSC
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$19,632$611.16+$3.62723524842849e+21M → STSC
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$21,963$682.53+$2.417368115915061e+25M → STSC
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$24,571$762.18+$1.5056740286145463e+29M → STSC
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$27,486$851.08+$8.764771002818475e+32M → STSC
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$30,745$950.29+$4.7683925249533696e+36M → STSC

STSC vs MRK: Complete Analysis 2026

STSC — Stock

Start Scientific, Inc. engages in the exploration, development, and production of oil and gas interests in the United States. It holds working interests in various oil and gas leases located in Yazoo County, Mississippi in the Pickens field. The company was formerly known as Secure Netwerks, Inc. and changed its name to Start Scientific, Inc. in November 2011. Start Scientific, Inc. was founded in 2004 and is based in Oklahoma City, Oklahoma.

Full STSC Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this STSC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STSC vs SCHDSTSC vs JEPISTSC vs OSTSC vs KOSTSC vs MAINSTSC vs JNJSTSC vs ABBVSTSC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.